Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Summit Therapeutics Inc. (SMMT)

17.61 +0.48 (+2.77%)
At close: September 4 at 4:00:00 PM EDT
17.63 +0.02 (+0.12%)
After hours: September 4 at 7:59:13 PM EDT
Trade SMMT on Coinbase

Financials

Updated 11h ago
Powered by Yahoo Scout

Summit Therapeutics Inc's financial performance shows significant challenges, particularly in growth metrics, with EBITDA growth declining by 13.41%in FY 2026 Q2, following a drastic decline of 405.40%in Q1. Profitability metrics remain stagnant, with gross and operating margins at 0.00%, indicating no retained earnings from sales. Overall, the company is facing a tough environment with no revenue growth and negative trends in profitability and earnings.

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
11.30B 11.56B 14.71B 13.56B 15.38B 15.81B
Enterprise Value
10.63B 10.98B 14.02B 13.33B 15.09B 15.45B
Trailing P/E
22.50 -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (5yr expected)
-- -- -- -- -- --
Price/Sales
-- -- -- -- -- --
Price/Book
17.93 21.17 22.33 70.53 59.28 45.91
Enterprise Value/Revenue
6.43k -- -- -- -- --
Enterprise Value/EBITDA
-5.32 -- -- -- -- --
6/30/2025 - 3/5/2015

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends --
Most Recent Quarter (mrq) --

Profitability

Profit Margin --
Operating Margin (ttm) --

Management Effectiveness

Return on Assets (ttm) --
Return on Equity (ttm) --

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) --
Total Cash Per Share (mrq) --
Total Debt (mrq) --
Total Debt/Equity (mrq) --
Current Ratio (mrq) --
Book Value Per Share (mrq) --

Cash Flow Statement

Operating Cash Flow (ttm) --
Levered Free Cash Flow (ttm) --

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Change 3 --
S&P 500 52-Week Change 3 --
52 Week High 3 --
52 Week Low 3 --
50-Day Moving Average 3 --
200-Day Moving Average 3 --

Share Statistics

Avg Vol (3 month) 3 --
Avg Vol (10 day) 3 --
Shares Outstanding 5 --
Implied Shares Outstanding 6 --
Float 8 --
% Held by Insiders 1 --
% Held by Institutions 1 --
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 --
Trailing Annual Dividend Yield 3 --
5 Year Average Dividend Yield 4 --
Payout Ratio 4 --
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: